Newly Identified CYP2C93 Is a Functional Enzyme in Rhesus Monkey, but Not in Cynomolgus Monkey
2011

CYP2C93: A New Drug-Metabolizing Enzyme in Rhesus Monkeys

Sample size: 19 publication 10 minutes Evidence: moderate

Author Information

Author(s): Uno Yasuhiro, Uehara Shotaro, Kohara Sakae, Iwasaki Kazuhide, Nagata Ryoichi, Fukuzaki Koichiro, Utoh Masahiro, Murayama Norie, Yamazaki Hiroshi

Primary Institution: Shin Nippon Biomedical Laboratories, Ltd.

Hypothesis

CYP2C93 is a functional enzyme in rhesus monkeys but not in cynomolgus monkeys.

Conclusion

CYP2C93 is predominantly expressed in the liver of rhesus monkeys and can metabolize several human CYP2C substrates.

Supporting Evidence

  • CYP2C93 mRNA was predominantly expressed in the liver among various tissues analyzed.
  • CYP2C93 proteins metabolized human CYP2C substrates like diclofenac and flurbiprofen.
  • Functional transcript variant SV1 was found in 6 of 11 rhesus monkeys.
  • All analyzed cynomolgus monkeys expressed a nonfunctional variant of CYP2C93.

Takeaway

Researchers found a new enzyme in rhesus monkeys that helps break down certain drugs, but this enzyme doesn't work in a similar monkey species.

Methodology

The study involved cloning and characterizing CYP2C93 cDNA from liver tissues of cynomolgus and rhesus monkeys, followed by enzyme activity assays.

Potential Biases

Potential bias due to the authors' affiliation with a biomedical laboratory that may have vested interests in the findings.

Limitations

The study primarily focused on two monkey species, limiting the generalizability of findings to other species.

Participant Demographics

The study included 11 rhesus monkeys and 8 cynomolgus monkeys, with both male and female subjects.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016923

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication